Article
Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
European journal of endocrinology - 1 Apr 2009
Schreiner Felix, Tozakidou Magdalini, Maslak Rita, Holtkamp Ute, Peter Michael, Gohlke Bettina, Woelfle Joachim
Abstract excerpt
OBJECTIVE: 17-Hydroxyprogesterone (17-OHP) screening for classical congenital adrenal hyperplasia (CAH) is part of many newborn screening programs worldwide. Cut-off values are relatively high, and screening sensitivity does not reach 100%. Recently, the glucocorticoid receptor (GR) N363S-variant has been linked to relatively low degree of virilization and comparatively lower 17-OHP serum concentrations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
